Pompe patient
AREAS OF FOCUS

Across five therapeutic areas, we help people with debilitating and complex conditions that are often difficult to diagnose and treat

1
Addressing unmet medical needs
2
Exploring innovative technologies and treatment approaches
3
Improving the lives of patients worldwide

Unified by three key principles across the organization, our goal is a common one: addressing unmet medical needs, exploring innovative technologies and treatment approaches, and improving the lives of patients worldwide.

Since 1981, we have been recognized for developing pioneering treatments for rare diseases. Today, as the specialty care global business unit of Sanofi, we remain focused on developing these highly specialized treatments for patients and have extended our portfolio to include rare diseases, rare blood disorders, multiple sclerosis, oncology and immunology.

An innovator in RARE DISEASES
Focusing on uncommon and underserved medical conditions, our Rare Disease franchise is committed to empowering the lives of patients with rare diseases by offering sustainable, transformative healthcare options.

Committed to RARE BLOOD DISORDERS

We are committed to significantly improving the health and lives of people with rare blood disorders around the world through groundbreaking science.
A leader in MULTIPLE SCLEROSIS
We are committed to being a long-term partner to the multiple sclerosis (MS) community by working to deliver scientific advancements that will have a significant impact on the unmet needs of people living with MS.
Prostate cancer patient
Advancing scientific discovery in ONCOLOGY
Our relentless pursuit to advance scientific discovery in oncology is matched only by our determination to bring solutions to patients. Our pipeline offers an expanding diversity of opportunities to advance the potential treatment of a variety of cancers.
Researching new treatments in IMMUNOLOGY
Expanding our research focus, we are targeting unmet needs in immune diseases including atopic dermatitis, rheumatoid arthritis, asthma, nasal polyposis, and eosinophilic esophagitis.
Pipeline image
Our research pipeline
Explore our pipeline to seeĀ  highlights of our research programs in various stages of clinical development.
Products image
Portfolio of products
We have a specialized portfolio of 25+ products globally across our four therapeutic areas.
Sanofi Genzyme 2019 brochure (PDF)
We are the specialty care global business unit of Sanofi, focused on rare diseases, multiple sclerosis, oncology, immunology, and rare blood disorders.

This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.

Click here for more information on cookies.
OK